|
WO2020245054A1
|
|
Pd-1 axis binding antagonist to treat cancer with genetic mutations in specific genes
|
|
WO2021004608A1
|
|
Home stock management system
|
|
EP3761244A1
|
|
Home stock management system
|
|
EP3653734A1
|
|
New methods for species identification
|
|
AU2019274782A1
|
|
Method for controlling the afucosylation level of a glycoprotein composition
|
|
WO2020135916A1
|
|
Smart cabinet for a disposable container system
|
|
WO2020125980A1
|
|
Communication apparatus for use with electronic communication element, electronic communication element and uses thereof
|
|
CA3085405A1
|
|
Methods for modulating protein mannosylation profiles using maduramycin, narasin, or salinomycin
|
|
EP3666314A1
|
|
Injection device
|
|
EP3695410A1
|
|
Patient care system
|
|
EP3620785A1
|
|
Electrophoresis-based characterization of fc fusion proteins
|
|
CA3072129A1
|
|
Method for purifying proteins
|
|
EP3530303A1
|
|
Storage container for electronic injection device
|
|
WO2019161900A1
|
|
Storage container for electronic injection device
|
|
EP3461520A1
|
|
Smart cabinet for a disposable container system
|
|
CN109862880A
|
|
Composition of liquid medicine
|
|
WO2018046769A1
|
|
Methods for modulating production profiles of recombinant proteins
|
|
AU2017264541A1
|
|
Methods for modulating protein galactosylation profiles of recombinant proteins using peracetyl galactose
|
|
EP3399463A1
|
|
Method and apparatus for determining information about a drug-containing vessel
|
|
EP3398637A1
|
|
Tip determiner for an injection device
|
